[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-369420-105":59,"doc-detail-369420-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","oxphos-inhibition-overcomes-chemoresistance-in-triple-negative-breast-cancer","OXPHOS inhibition overcomes chemoresistance in triple negative breast cancer","","The hypothesis of a significant shift from oxidative phosphorylation (OXPHOS) to glycolysis in many solid tumors has dominated research for years. Accumulating evidence indicates that OXPHOS is the main energy production mode in numerous cancers, particularly after chemo- or radiotherapy and in chemoresistant malignancies. Here, chemoresistant triple-negative breast cancer cells rely more on OXPHOS than chemosensitive cells and can be targeted by OXPHOS inhibitors.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/oxphos-inhibition-overcomes-chemoresistance-in-triple-negative-breast-cancer/369420/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/oxphos-inhibition-overcomes-chemoresistance-in-triple-negative-breast-cancer/369420.png","ImageObject",300,407,{"name":92,"@type":93},"Jacob","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-12","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What metabolic preference do chemoresistant triple-negative breast cancer cells show?","Question",{"text":112,"@type":113},"They preferentially obtain energy via oxidative phosphorylation (OXPHOS) to a greater extent than chemosensitive cells.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were candidate drugs identified in the study?",{"text":117,"@type":113},"From a library of several dozen antimicrobials, the authors selected compounds that inhibit OXPHOS in resistant TNBC cells and cause mitochondrial dysfunction.",{"name":119,"@type":110,"acceptedAnswer":120},"What did animal experiments demonstrate about the selected OXPHOS inhibitors?",{"text":121,"@type":113},"The selected inhibitors preferentially suppressed tumor growth derived from chemoresistant cells, not those from chemosensitive cells.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},369420,1790366595,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},962084931830,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","Redox Biology 83 (2025) 103637  \nContents lists available at ScienceDirect  \nRedox Biology  \njournal [homepage:](homepage: www.elsevier.com/locate/redox)[ www.elsevier.com/locate/redox](homepage: www.elsevier.com/locate/redox)  \n| OXPHOS inhibition overcomes chemoresistance in triple negative breast cancer\u003Cbr>Cemile Uslu 1, Eda Kapan 1, Alex Lyakhovich * \u003Cbr>Sabanci University, Molecular Biology, Genetics and Bioengineering, Faculty of Engineering and Natural Sciences, Turkey |  |  |\n| --- | --- | --- |\n| A R T I C L E I N F O |  | A B S T R A C T |\n| Keywords:\u003Cbr>Oxidative phosphorylation Cancer resistance\u003Cbr>Triple negative breast tumors Mitochondria\u003Cbr>Autophagy\u003Cbr>Antimicrobials |  | The hypothesis of a significant shift from oxidative phosphorylation (OXPHOS) to glycolysis in a number of solid tumors has been dominant for many years. Recently, however, evidence has begun to accumulate that OXPHOS is the major mode of energy production in many neoplasias, especially those that have undergone chemo- or radiotherapy, and especially in chemoresistant malignancies. In the present work, we demonstrated that chemoresistant triple-negative breast cancer cells prefer to obtain energy via OXPHOS to a greater extent than cells sensitive to chemotherapeutic agents, and therefore the former can be affected by some OXPHOS inhibitors. From a drug library containing several dozen antimicrobials, we selected those that inhibit OXPHOS in resistant TNBC cells and lead to mitochondrial dysfunction. We have also identified several pathways by which inhibition of growth suppression of chemoresistant cells occurs, including increased oxidative stress and mitophagy. Experiments in mice showed that selected OXPHOS inhibitors preferentially suppress tumor growth from chemoresistant but not from chemosensitive cells. The results of the present study suggest combinatorial therapy of such inhibitors and conventional anticancer drugs on resistant forms of tumors, if the latter show enhanced OXPHOS. |\n\n1. Introduction  \nDespite undoubted progress in the treatment of breast cancer (BC), which ranks first among the causes of cancer-related mortality in women [1], the 5-year survival rate of patients remains relatively low, and for some forms of BC, especially distant triple negative breast cancer (TNBC) is only 12 %[2]. The standard treatment modalities for BC patients are surgical destruction followed by radio- and/or chemotherapy. TNBC, one of the most common histologic subtypes of BC, initially responds well to platinum- or phosphamide-based chemotherapy, but over time patients relapse and develop chemoresistance [3]. The development of chemoresistance is a major obstacle to improving survival of BC patients, as it leads to metastasis and eventually death of patients [4].  \nIn most solid tumors, including TNBC, a set of different and not fully understood mechanisms is responsible for the development of chemoresistance and disease recurrence [5]. In particular, the hypothesis put forward by Otto Warburg about the transition of cancer cells to the glycolytic pathway of energy production even in the presence of  \nsufficient oxygen, dominated for many years [6,7]. Later, after detailed elucidation of mitochondrial functions, it was modified into the hypothesis of metabolic switching implying the transition of cell bioenergetics from oxidative phosphorylation (OXPHOS) to glycolysis [8]. This hypothesis also raised certain questions about higher energy demand of proliferating cancer cells, but was partially explained by the faster kinetics of glycolysis in relation to OXPHOS [9]. Recently, however, numerous data have begun to accumulate that OXPHOS is the major mode of energy production in many malignant tumors, particularly those exposed to chemo-or radiotherapy [10]. For example, there are many studies showing overexpression of OXPHOS genes and proteins in ovarian [11,12], breast [13], colon [14–16] lung [17], pancreatic cancers [18,19] as well as in acut","cbCaikqF2T3s1WRs","https://ap.wps.com/l/cbCaikqF2T3s1WRs","pdf",8314829,13,"English","# Introduction\n# Results\n# Discussion","[{\"question\":\"What metabolic preference do chemoresistant triple-negative breast cancer cells show?\",\"answer\":\"They preferentially obtain energy via oxidative phosphorylation (OXPHOS) to a greater extent than chemosensitive cells.\"},{\"question\":\"How were candidate drugs identified in the study?\",\"answer\":\"From a library of several dozen antimicrobials, the authors selected compounds that inhibit OXPHOS in resistant TNBC cells and cause mitochondrial dysfunction.\"},{\"question\":\"What did animal experiments demonstrate about the selected OXPHOS inhibitors?\",\"answer\":\"The selected inhibitors preferentially suppressed tumor growth derived from chemoresistant cells, not those from chemosensitive cells.\"}]","OXPHOS inhibition overcomes chemoresistance in triple negative breast cancer | PDF",1790182581,33,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/88be701690bafe36a086e606e6b32bc9.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/af409e5506a0cb6deaf839ad1ed31971.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fd8a668e2315a49693c06e2694721ed0.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/99ca1819fcef0fe91bff1b58458e2402.webp",980,1306]